PDB30 A MODELLED COST-EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO INSULIN DETEMIR FROM ORAL ANTIDIABETICS OR NPH IN THE AUSTRIAN SETTING; DATA FROM THE PREDICTIVE STUDY
May 1, 2008, 00:00
10.1016/S1098-3015(10)70718-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)70718-X/fulltext
Title :
PDB30 A MODELLED COST-EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO INSULIN DETEMIR FROM ORAL ANTIDIABETICS OR NPH IN THE AUSTRIAN SETTING; DATA FROM THE PREDICTIVE STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70718-X&doi=10.1016/S1098-3015(10)70718-X
First page :
Section Title :
Open access? :
No
Section Order :
459